Exact Mass: 392.0831

Exact Mass Matches: 392.0831

Found 65 metabolites which its exact mass value is equals to given mass value 392.0831, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Hosloppin

5-Hydroxy-6- (5-hydroxy-6-methyl-4-oxo-4H-pyran-3-yl) -7-methoxy-2-phenyl-4H-1-benzopyran-4-one

C22H16O7 (392.0896)

8-C-p-Hydroxybenzylkaempferol

3,5,7,4-Tetrahydroxy-8- (4-hydroxyphenylmethyl) flavone

C22H16O7 (392.0896)

ethyl 3-[(ethoxycarbonyl)methyl]-4,6-dihydro-8,9-dihydroxy-2,6-dioxo-2H-pyrano[3,4,5-de]chromene-4-carboxylate|pomegranatate

C18H16O10 (392.0743)

CHEMBL225917

C22H16O7 (392.0896)

Rhodolauradiol acetate|Rhodolauradiol monoacetate

C17H26BrClO3 (392.0754)

2-C-??-D-Xylopyranosyl-1,3,6,7-tetrahydroxyxanthone

C18H16O10 (392.0743)

5-acetoxyoxachamigrene

C17H26BrClO3 (392.0754)

8-p-Hydroxybenzylluteolin

C22H16O7 (392.0896)

cimicifugic acid H

C18H16O10 (392.0743)

(+)-acetodalmanol A

C22H16O7 (392.0896)

4,5,7-trihydroxy-6-(3,4-dihydroxybenzyl)flavone|6-(3,4-dihydroxybenzyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

C22H16O7 (392.0896)

phelliribsin A

C22H16O7 (392.0896)

Resistoflavine

C22H16O7 (392.0896)

Jusmicranthin ethyl ether

C22H16O7 (392.0896)

Annotation level-1

Bisanhydrorutilantinone_major

C22H16O7 (392.0896)

Abu-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-ethoxy-4-nitrobenzamido)propanoic acid

C18H17ClN2O6 (392.0775)

Phe4Cl-Abu-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)pentanoic acid

C18H17ClN2O6 (392.0775)

Parecoxib sodiuM

C19H17N2NaO4S (392.0807)

D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents

METHYL 1-(4-(TRIFLUOROMETHYL)PHENYL)-5-(4-(METHYLTHIO)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

C19H15F3N2O2S (392.0806)

N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-p-toluenesulphonamide

C21H16N2O4S (392.0831)

((2R,3R,4R,5R)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate

C20H18ClFO5 (392.0827)

((2R,3R,4R,5S)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate

C20H18ClFO5 (392.0827)

2-Propanesulfonamide, N-((3S,4S)-4-(4-(5-cyano-2-thienyl)phenoxy)tetrahydro-3-furanyl)-

C18H20N2O4S2 (392.0864)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pesampator (PF-04958242) is a potent and highly selective positive allosteric modulator of AMPA receptor (an AMPA potentiator) with an EC50 of 310 nM and a Ki of 170 nM[1].

Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate

C21H16N2O4S (392.0831)

Methyl 6,11-dihydro-6,11-dioxo-2-ethyl-5,7,9-trihydroxy-1-naphthacenecarboxylate

C22H16O7 (392.0896)

4-[[[4-(2-Furanylmethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile

C20H16N4OS2 (392.0765)

(4-oxopyrimido[2,1-b][1,3]benzothiazol-2-yl)methyl (E)-3-(4-methoxyphenyl)prop-2-enoate

C21H16N2O4S (392.0831)

(6R,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

(6S,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

(6R,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

(6S,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

(6S,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

(6S,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

(6R,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

(6R,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21BrN2O3 (392.0735)

[4-[3-[3,5-dihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]oxiran-2-yl]phenyl] hydrogen sulate

C19H20O7S (392.093)

2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one

C22H16O7 (392.0896)

(2r,3s)-2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-(4-hydroxybenzoyloxy)butanedioic acid

C18H16O10 (392.0743)

2'-acetyl-5-[2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one

C22H16O7 (392.0896)

2-c-β-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone

C18H16O10 (392.0743)

{"Ingredient_id": "HBIN005454","Ingredient_name": "2-c-\u03b2-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone","Alias": "NA","Ingredient_formula": "C18H16O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}